SELECTIS HEALTH, INC. (GBCS) Form 8-K — Sep 8, 2026
$GBCSForm 8-KItems 1.01, 2.01, 3.03, 5.01, 5.02, 7.01, 9.01Filed Sep 8, 2026, 9:36 PM ET0001493152-26-041840Original filing
Selectis Health, Inc. has completed its take-private. Merger Sub accepted all shares validly tendered, and upon completion of the merger each outstanding share was cancelled and converted into the right to receive $5.75 in cash, making Selectis a wholly owned subsidiary of Black Pearl Equities II, LLC. The roughly $17,635,589 in aggregate cash consideration plus transaction fees was funded with $18,226,250 in term loans from Milrose Capital, LLC and SCG Experts Corp.
Key figures
- Debt Amount
- 18226250
- Deal Value Usd
- 17635589
- Interest Rate
- 5.0% fixed per annum
- Maturity Date
- August 28, 2031
- Late charge
- 5.0%
- First payment date
- September 1, 2027
- Default interest rate
- 24.0%
- Merger consideration per share
- 5.75
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.